Incyte Corp (NASDAQ:INCY)

94.36
Delayed Data
As of Mar 27
 +5.16 / +5.78%
Today’s Change
40.30
Today|||52-Week Range
99.00
+29.07%
Year-to-Date

Today’s Trading

Previous close89.20
Today’s open89.72
Day’s range89.05 - 95.72
Volume1,401,500
Average volume (3 months)1,187,645
Market cap$16.2B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+15.65%
Earnings growth (next 5 years)+209.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...+2.23+2.54%
HSPHospira Inc+0.03+0.03%
MNKMallinckrodt Plc+2.83+2.23%
PCYCPharmacyclics Inc+0.19+0.07%
Data as of 4:14pm ET, 03/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account